Preclinical study of a controlled release oral morphine system in rats

International Journal of Pharmaceutics

Volumn 139, Issue 1-2, 1996, Pages 237-241

  Alvarez Fuentes, J ^a   Fernandez Arevalo M ^a   Holgado, M A ^a   Caraballo, I ^a   Rabasco, A M ^a   Mico J A ^b   Rojas, O ^b   Ortega Alvaro, A ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

Analgesia; Chronic pain; Controlled release; Eudragit L30D; Morphine hydrochloride; MST Continus ; Severe pain; Tail flick test

Indexed keywords

EUDRAGIT; MORPHINE; MORPHINE SULFATE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC PAIN; COMPLEX FORMATION; CONTROLLED STUDY; DISSOLUTION; DRUG RELEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUSTAINED RELEASE PREPARATION; TAIL FLICK TEST;

EID: 0030576595     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04612-1     Document Type: Article

References (10)

1. Alvarez-Fuentes, J., Estandarización de una técnica de elaboración de complejos de morfina para su liberación controlada. Diseño y evaluación. Tesis de Licenciatura, Universidad de Sevilla (1992).
2. Alvarez-Fuentes, J., Fernández-Arévalo, M., Holgado, M.A., Caraballo, I., Llera, J.M. and Rabasco, A.M., Morphine polymeric coprecipitates for controlled release: elaboration and characterization. Drug Dev. Ind. Pharm., 20 (1994) 2409-2424.
3. Caraballo, I., Alvarez-Fuentes, J., Holgado, M.A., Fernández-Arévalo, M. and Rabasco, A.M., Studies on the formation and kinetic release of morphine polymeric complexes. Abstracts Book of 1st European Congress of Pharmaceutical Sciences, Amsterdam, 1992, p. 71.
4. D'Amour, F.E. and Smith, D.L., A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72 (1941) 74-77.
5. Fernández-Arévalo, M., Holgado, M.A., Alvarez-Fuentes, J., Caraballo, I., Vela, M.T. and Rabasco, A.M., Water-insoluble complexes of morphine and carteolol-Eudragit® L. A comparative study of the complexation process. Proceedings of 13th Pharmaceutical Technology Conference, Strasbourg, 1994, vol. 3, pp. 158-181.
6. Hanks, G.W., Hanna, M., Finlay, I., Radstone, D.J. and Keeble, T., Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200 mg tablet. J. Pain Symptom Manage., 10 (1995) 6-12.
7. Holgado, M.A., Fernández-Arévalo, M., Alvarez-Fuentes, J., Caraballo, I., Llera, J.M. and Rabasco, A.M., Physical characterization of carteolol-Eudragit® L binding interaction. Int. J. Pharm., 114 (1995) 13-21.
8. International Association for the study of pain (IAPS), Ethical standards for investigations of experimental pain in animals. Pain, 9 (1980) 141-142.
9. Marín Bosca, M.T., Ismail Salem, I., Sánchez Morcillo, J. and Cerezo, A., Dissolution study of prolonged release morphine tablets using hydrophillic matrices. Drug Dev. Ind. Pharm., 21 (1995) 1557-1562.
10. World Health Organization, Cancer Pain Relief, WHO, Geneva, 1986, pp. 5-70.